Effect of Citalopram on Emotion Processing in Humans: A Combined 5-HT1A [11C]CUMI-101 PET and Functional MRI Study
Open accessThe DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.
Abstract
A subset of patients started on a selective serotonin reuptake inhibitor (SSRI) initially experience increased anxiety, which can lead to early discontinuation before therapeutic effects are manifest. The neural basis of this early SSRI effect is not known. Presynaptic dorsal raphe neuron (DRN) 5-HT1A receptors are known to have a critical role in affect processing. Thus we investigated the effect of acute citalopram on emotional processing and the relationship between DRN 5-HT1A receptor availability and amygdala reactivity. Thirteen (mean age 48±9 years) healthy male subjects received either a saline or citalopram infusion intravenously (10 mg over 30 min) on separate occasions in a single-blind, random order, crossover design. On each occasion, participants underwent a block design face-emotion processing task during fMRI known to activate the amygdala. Ten subjects also completed a positron emission tomography (PET) scan to quantify DRN 5-HT1A availability using [11C]CUMI-101. Citalopram infusion when compared with saline resulted in a significantly increased bilateral amygdala responses to fearful vs neutral faces (left p=0.025; right p=0.038 FWE-corrected). DRN [11C]CUMI-101 availability significantly positively correlated with the effect of citalopram on the left amygdala response to fearful faces (Z=2.51, p=0.027) and right amygdala response to happy faces (Z=2.33, p=0.032). Our findings indicate that the initial effect of SSRI treatment is to alter processing of aversive stimuli and that this is linked to DRN 5-HT1A receptors in line with evidence that 5-HT1A receptors have a role in mediating emotional processing.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Power failure: why small sample size undermines the reliability of neuroscience
Button, K. S., Ioannidis, J. P. A., Mokrysz, C., Nosek, B. A., Flint, J., Robinson, E. S. J., & Munafò, M. R. (2013) · Nature Reviews Neuroscience · doi:10.1038/nrn3475 · Cited by 7,641 · cited 2×
“Furthermore, analysis of smaller sample sizes, as reported here, is known to provide inflated estimates of effect sizes (Button et al, 2013).”
BackgroundCircular analysis in systems neuroscience: the dangers of double dipping
Kriegeskorte, N., Simmons, W. K., Bellgowan, P. S. F., & Baker, C. I. (2009) · Nature Neuroscience · doi:10.1038/nn.2303 · Cited by 2,696
Consensus Nomenclature for in vivo Imaging of Reversibly Binding Radioligands
Innis, R. B., Cunningham, V. J., Delforge, J., Fujita, M., Gjedde, A., Gunn, R. N., Holden, J., Houle, S., Huang, S.-C., Ichise, M., et al. (2007) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/sj.jcbfm.9600493 · Cited by 1,955
Sheline, Y. I., Barch, D. M., Donnelly, J. M., Ollinger, J. M., Snyder, A. Z., & Mintun, M. A. (2001) · Biological Psychiatry · doi:10.1016/s0006-3223(01)01263-x · Cited by 1,191 · cited 2×
“Functional magnetic resonance imaging (fMRI) studies have revealed that depressed patients have exaggerated amygdala reactivity as measured using blood-oxygen-level-dependent (BOLD) responses when presented with emotions of negative valence (fearful or sad faces) and 8 weeks of SSRI treatment attenuates this to ‘norma…”
BackgroundMethodNational Patterns in Antidepressant Medication Treatment
Olfson, M., & Marcus, S. C. (2009) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2009.81 · Cited by 730 · cited 1×
“Selective serotonin reuptake inhibitors (SSRIs) are the most commonly prescribed medications for anxiety and depressive disorders worldwide (Olfson and Marcus, 2009).”
BackgroundPharmacological characterization of selective serotonin reuptake inhibitors (SSRIs)
Hyttel, J. (1994) · International Clinical Psychopharmacology · doi:10.1097/00004850-199403001-00004 · Cited by 492 · cited 2×
“Citalopram is one of the most selective SSRI compared with fluoxetine, paroxetine, sertraline, or fluvoxamine and has high affinity to serotonin transporter (5-HTT) without any significant affinity for other serotonergic (5-HT1A, 5-HT1B, or 5-HT2A/C), adrenergic, cholinergic, or other neurotransmitters and (Hyttel, 19…”
BackgroundAlbert, P. R., Vahid-Ansari, F., & Luckhart, C. (2014) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2014.00199 · Cited by 321
Serotonin, inhibition, and negative mood
Dayan, P., & Huys, Q. J. M. (2008) · PLoS Computational Biology · doi:10.1371/journal.pcbi.0040004 · Cited by 263 · cited 1×
“Serotonin, or 5-hydroxytryptamine (5-HT), is thought to be critical for affect regulation in the brain (Dayan and Huys, 2008), and SSRIs are thought to act primarily by altering 5-HT function.”
BackgroundDel-Ben, C. M., Deakin, J. F. W., Mckie, S., Delvai, N. A., Williams, S. R., Elliott, R., Dolan, M., & Anderson, I. M. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300728 · Cited by 260 · cited 5×
“Second, although N= 13 is comparable to the size of similar studies (Bigos et al, 2008; Del-Ben et al, 2005), the sample size for the combined PET/fMRI experiment does not permit investigation of additional potential moderators (eg, 5-HTT genetic polymorphisms) on the influence of the 5-HT1A…”
BackgroundMethodResultInfluentialMumford, J. A., & Nichols, T. E. (2008) · NeuroImage · doi:10.1016/j.neuroimage.2007.07.061 · Cited by 252 · cited 1×
“A substantially larger sample (eg, N478 for the fearful vs neutral face citalopram contrasts; cf., fmripower.org; (Mumford and Nichols, 2008) will be required to establish well-powered effect size estimates.”
Background
Cited by
Toward a neurocircuit-based taxonomy to guide treatment of obsessive-compulsive disorder
Shephard, E., Stern, E. R., van den Heuvel, O. A., Costa, D. L. C., Batistuzzo, M. C., Godoy, P. B. G., Lopes, A. C., Brunoni, A. R., Hoexter, M. Q., Shavitt, R. G., et al. (2021) · Molecular Psychiatry · doi:10.1038/s41380-020-01007-8 · Cited by 250
Cognitive Control as a 5-HT1A-Based Domain That Is Disrupted in Major Depressive Disorder
Langenecker, S. A., Mickey, B. J., Eichhammer, P., Sen, S., Elverman, K. H., Kennedy, S. E., Heitzeg, M. M., Ribeiro, S. M., Love, T. M., Hsu, D. T., et al. (2019) · Frontiers in Psychology · doi:10.3389/fpsyg.2019.00691 · Cited by 18
“The anatomical cross-localization could be off in such instances, and the measurements could be weakened by daysession specific parameters (Selvaraj et al., 2017; Hamilton et al., 2018).”
BackgroundLukow, P. B., Lowther, M., Pike, A. C., Yamamori, Y., Chavanne, A. V., Gormley, S., Aylward, J., McCloud, T., Goble, T., Rodriguez-Sanchez, J., et al. (2024) · Journal of Psychopharmacology · doi:10.1177/02698811241286773 · Cited by 3
“…an increase or no change in amygdala activation (decrease: Del-Ben et al., 2005; Grady et al., 2013; Harmer et al., 2006; Murphy et al., 2009; Windischberger et al., 2010; increase: Bigos et al., 2008; Selvaraj et al., 2017; no change: Brühl et al., 2009; Hornboll et al., 2018; Klomp et al., 2013).”
Background
Metadata
- Authors
- Selvaraj, S., Walker, C., Arnone, D., Cao, B., Faulkner, P., Cowen, P. J., Roiser, J. P., & Howes, O.
- Venue
- Neuropsychopharmacology
- Published
- 2017-08-04
- Volume
- 43
- Issue
- 3
- Pages
- 655-664
- ISSN
- 0893-133X (ISSN-L)
- 1740-634X
- OpenAlex
- W2743855088
- Cited by
- 58
- References
- 16
- FWCI
- 0.82
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Effect of Citalopram on Emotion Processing in Humans: A Combined 5-HT1A [11C]CUMI-101 PET and Functional MRI Study. https://app.cochat.ai/papers/10.1038/npp.2017.166
- The paper
- Selvaraj, S., Walker, C., Arnone, D., Cao, B., Faulkner, P., Cowen, P. J., Roiser, J. P., & Howes, O. (2018). Effect of Citalopram on Emotion Processing in Humans: A Combined 5-HT1A [11C]CUMI-101 PET and Functional MRI Study. Neuropsychopharmacology. https://doi.org/10.1038/npp.2017.166
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.